HMGB1 and Sepsis: While inhibiting LDHA activity primarily mitigates sepsis progression and improves survival by diminishing lactate production and, consequently, lactate-mediated toxic effects, e.g., HMGB1 release by macrophages, it also hinders the Warburg phenotype in macrophages and neutrophils, thereby limiting excessive inflammatory responses.